Poster Poster Program Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Characterization of Delayed Imaging Quantitative Accuracy on a Long-Axial Field-of-View Total-Body PET Scanner

Abstract
Purpose

To quantify radiotracer- and reconstruction-dependent feasibility of delayed PET imaging on a long axial field-of-view (LAFOV) system, and to identify pediatric-relevant delayed imaging windows (or equivalent low-activity protocols) while maintaining small-lesion quantitative performance.

Methods

A NEMA NU-2 image quality phantom (six spheres: 10–37 mm) was imaged using five PET radiotracers (F-18, C-11, N-13, Ga-68, Cu-64) with 30-min acquisitions at serial delays through 10 half-lives (analysis at HL1/2/4/6/8/10). Reconstructions included TOF+PSF OSEM (3 iterations, 10 subsets, no post-filter), vendor-provided Hyper-Iterative (HI), and Deep Progressive Reconstruction (DPR) when available (F-18, C-11, Ga-68). Metrics included target-to-background ratio (TBR), contrast recovery coefficient (CRC), background variability (BV%), lesion variability (LV%), and pooled contrast-to-noise ratio (CNR_p). Uncertainty-based 95% confidence intervals (CI) for TBR and CRC were computed by error propagation.

Results

Small spheres (10–13 mm) governed feasibility. Under a balanced pediatric decision rule (CRC 95% CI ≥ 0 .70, BV% ≤ 25, and size-dependent CNR_p thresholds), the maximum feasible delays for 10–13 mm targets were: C-11 up to HL4 (HI), N-13 up to HL6 (HI), Ga-68 up to HL6 (DPR), F-18 up to HL8 (HI), and Cu-64 up to HL4 (OSEM). These correspond to remaining activity fractions of 1/16, 1/64, 1/64, 1/256, and 1/16, respectively.

Conclusion

LAFOV PET enables extended delayed (low-count) imaging windows that are tracer- and reconstruction-dependent. Uncertainty-based constraints support conservative pediatric protocol optimization and provide objective bounds for activity reduction while preserving small-lesion quantitative performance.

People

Related

Similar sessions

Poster Poster Program
Jul 19 · 07:00
Adverse Events in Targeted Radionuclide Therapy

Radiopharmaceutical therapy (RPT) plays an important role in the management of oncology patients, particularly those with thyroid cancer, prostate cancer, and neuroendocrine tumor. The use of radionuclide therapy has expanded rap...

Harrison L. Agordzo
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Development of a Web-Based Theranostic Workflow Management Tool

To develop a Web-Based Theranostic Workflow Management Tool (TWMT) to efficiently manage Theranostic program in the department of radiation oncology (RadOnc).

Ling Zhuang, PhD
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Epidseg-Net:the Multi-Modal Fusion Framework Based on Drr Guidance In Radiotherapy Is Used for Precise Segmentation of Epid Lung Targets

The proposed multimodal segmentation framework, named EPIDSeg-Net, comprises an encoder, a multi-scale feature layer, and a decoder. The encoder utilizes a dual-branch architecture: a CNN branch for extracting local texture featu...

Huang Qian Qianjia, M.Eng
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested